Q: What is Kaliumchloride Fresenius Kabi used for?

Kaliumchloride Fresenius Kabi is an intravenous potassium chloride solution used to treat hypokalemia and to provide potassium replacement during conditions such as surgery, dialysis, or other situations where potassium loss occurs. It helps restore normal serum potassium levels and supports proper cardiac and muscular function.

Question 1

What is Kaliumchloride Fresenius Kabi used for?

Accepted Answer

Kaliumchloride Fresenius Kabi is an intravenous electrolyte that acts on potassium balance pathways to restore normal serum levels.

Hypokalemia: restores normal potassium concentrations in patients with low serum potassium. Potassium replacement therapy: provides potassium during surgery, dialysis, or other conditions causing depletion. Cardiac arrhythmia prevention: helps maintain cardiac electrical stability in patients at risk due to potassium deficiency.

Question 2

How does potassium chloride work in the body?

Accepted Answer

After intravenous administration, potassium chloride dissociates into potassium ions that enter the extracellular fluid. The increased extracellular potassium shifts the electrochemical gradient across cell membranes, facilitating repolarization of cardiac and skeletal muscle cells, correcting low potassium levels, and maintaining normal cellular excitability.

Question 3

What determines the usual dose of Kaliumchloride Fresenius Kabi?

Accepted Answer

The dose of Kaliumchloride Fresenius Kabi is individualized by the prescribing clinician based on the patient’s current serum potassium concentration, renal function, cardiac status, and the rate of potassium loss. The prescriber calculates the required amount to safely raise potassium to the target range.

Question 4

Is Kaliumchloride Fresenius Kabi safe during pregnancy or breastfeeding?

Accepted Answer

Safety data for potassium chloride in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional after evaluating the clinical situation.

Question 5

How do I order Kaliumchloride Fresenius Kabi from GNH USA?

Accepted Answer

To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and necessary import documentation.

Question 6

How does Kaliumchloride Fresenius Kabi compare with other potassium supplements?

Accepted Answer

Kaliumchloride Fresenius Kabi is an injectable formulation, allowing rapid correction of potassium deficits in acute settings, whereas oral potassium salts are slower and used for chronic management. The IV product offers precise dosing and immediate bioavailability, which is essential for severe hypokalemia or when oral intake is not feasible.

Question 7

How should Kaliumchloride Fresenius Kabi be stored and handled?

Accepted Answer

The solution must be stored at 2‑8 °C, kept refrigerated, protected from light, and should never be frozen or shaken. Before use, inspect the container for particulate matter or discoloration, and follow aseptic techniques to prevent contamination during preparation and administration.

Question 8

How is Kaliumchloride Fresenius Kabi administered to patients?

Accepted Answer

Kaliumchloride Fresenius Kabi is administered intravenously by a qualified healthcare professional. The infusion rate is carefully controlled, typically not exceeding 10‑20 mmol per hour, to minimize the risk of local irritation and rapid shifts in serum potassium. Monitoring of cardiac rhythm and serum potassium is recommended during and after infusion.

Question 9

What are the most serious risks associated with Kaliumchloride Fresenius Kabi?

Accepted Answer

The most serious risks include severe hyperkalemia, which can cause life‑threatening cardiac arrhythmias or cardiac arrest, as well as anaphylactic reactions and thrombophlebitis at the infusion site. Prompt recognition and immediate medical intervention are essential if these events occur.

Question 10

Who should not receive Kaliumchloride Fresenius Kabi?

Accepted Answer

Patients with known hypersensitivity to potassium chloride or any component of the formulation should avoid the product. It is also contraindicated in individuals with severe renal failure, uncontrolled hyperkalemia, or conditions where rapid potassium elevation could precipitate dangerous cardiac events.